Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Moore

Showing results (211-220 of 269) with videos related to

Pageof 27
Sort By:
Global Change Biology|May 28, 2019
Linking drought legacy effects across scales: From leaves to tree rings to ecosystemsSteven A Kannenberg, Kimberly A Novick, M Ross Alexander, et al.
Journal of Virology|December 1, 1994
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1M K Gorny, J P Moore, A J Conley, et al.
Journal of Virology|January 3, 2001
Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140A Trkola, T J Ketas, K A Nagashima, et al.
Journal of Virology|October 6, 1997
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropismM Pope, S S Frankel, J R Mascola, et al.
Journal of Virology|October 1, 1993
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domainsJ P Moore, Q J Sattentau, H Yoshiyama, et al.
Lancet (London, England)|November 30, 1999
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresisB Ramratnam, S Bonhoeffer, J Binley, et al.
AIDS Research and Human Retroviruses|December 1, 1993
Nonaffinity purification of recombinant gp120 for use in AIDS vaccine developmentC J Scandella, J Kilpatrick, W Lidster, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assaysJ P Moore, Y Cao, A J Conley, et al.
Ecology Letters|March 19, 2013
Persistent reduced ecosystem respiration after insect disturbance in high elevation forestsDavid J P Moore, Nicole A Trahan, Phil Wilkes, et al.
Nature Medicine|March 21, 1998
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutationL G Kostrikis, Y Huang, J P Moore, et al.
Pageof 27

Showing results (211-220 of 269) with videos related to

Sort By:
Pageof 27
Global Change Biology|May 28, 2019
Linking drought legacy effects across scales: From leaves to tree rings to ecosystemsSteven A Kannenberg, Kimberly A Novick, M Ross Alexander, et al.
Journal of Virology|December 1, 1994
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1M K Gorny, J P Moore, A J Conley, et al.
Journal of Virology|January 3, 2001
Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140A Trkola, T J Ketas, K A Nagashima, et al.
Journal of Virology|October 6, 1997
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropismM Pope, S S Frankel, J R Mascola, et al.
Journal of Virology|October 1, 1993
Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domainsJ P Moore, Q J Sattentau, H Yoshiyama, et al.
Lancet (London, England)|November 30, 1999
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresisB Ramratnam, S Bonhoeffer, J Binley, et al.
AIDS Research and Human Retroviruses|December 1, 1993
Nonaffinity purification of recombinant gp120 for use in AIDS vaccine developmentC J Scandella, J Kilpatrick, W Lidster, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assaysJ P Moore, Y Cao, A J Conley, et al.
Ecology Letters|March 19, 2013
Persistent reduced ecosystem respiration after insect disturbance in high elevation forestsDavid J P Moore, Nicole A Trahan, Phil Wilkes, et al.
Nature Medicine|March 21, 1998
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutationL G Kostrikis, Y Huang, J P Moore, et al.
Pageof 27